Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Ultragenyx Pharmaceutical Inc (RARE)  
$42.75 0.45 (1.04%) as of 4:30 Fri 5/3


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 82,110,000
Market Cap: 3.51(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $31.73 - $53.69
Level I Sector: Consumer Discretionary
Level II Sector: Leisure
Level III Sector: Restaurants

Member Indexes:
    S&P COMPOSITE 1500     NASDAQ COMPOSITE
    NASDAQ INDUSTRIAL     S&P SMALLCAP 600
    NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Ultragenyx Pharmaceutical is a biopharmaceutical company focused on the identification, acquisition, development, and commercialization of products for the treatment of genetic diseases. Co. has four commercially approved products, Crysvita® (burosumab) for the treatment of X-linked hypophosphatemia and tumor-induced osteomalacia, Mepsevii® (vestronidase alfa) for the treatment of mucopolysaccharidosis VII, or Sly Syndrome, Dojolvi® (triheptanoin) for the treatment of long-chain fatty acid oxidation disorders, and Evkeeza® (evinacumab) for the treatment of homozygous familial hypercholesterolemia.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 69,133 99,133 200,384 249,340
Total Sell Value $3,373,178 $4,809,278 $8,291,909 $10,478,837
Total People Sold 8 8 9 12
Total Sell Transactions 10 11 20 34
End Date 2024-02-04 2023-11-03 2023-05-05 2022-05-05

   
Records found: 628
  Page 3 of 26  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Huizenga Theodore Alan SVP, Chief Accounting Officer   •       –      –    2023-05-09 4 OE $21.00 $63,000 D/D 3,000 30,747     -
   Parschauer Karah Herdman EVP and Chief Legal Officer   •       –      –    2023-05-04 4 AS $45.00 $197,010 D/D (4,378) 51,982 -11%     
   Crombez Eric EVP and Chief Medical OfficerO   •       –      –    2023-05-01 3 IO $0.00 $0 D/D 0 25,854 -7%     
   Crombez Eric EVP and Chief Medical Officer   •       –      –    2023-05-01 4 A $0.00 $0 D/D 4,658 30,512     -
   Huizenga Theodore Alan SVP, Chief Accounting Officer   •       –      –    2023-04-16 4 D $38.20 $6,914 D/D (181) 27,520     -
   Huizenga Theodore Alan SVP, Chief Accounting Officer   •       –      –    2023-04-16 4 D $38.20 $535 D/D (14) 27,701     -
   Kakkis Emil D President & CEO   •       •      –    2023-03-01 4 D $45.65 $736,791 D/D (16,140) 599,176     -
   Kakkis Emil D President & CEO   •       •      –    2023-03-01 4 A $0.00 $0 D/D 54,916 615,606     -
   Harris Erik EVP & Chief Commercial Officer   •       –      –    2023-03-01 4 S $45.25 $165,796 D/D (3,664) 57,344 4%     
   Harris Erik EVP & Chief Commercial Officer   •       –      –    2023-03-01 4 A $0.00 $0 D/D 24,663 60,823     -
   Huizenga Theodore Alan SVP, Chief Accounting Officer   •       –      –    2023-03-01 4 D $45.65 $60,851 D/D (1,333) 21,715     -
   Huizenga Theodore Alan SVP, Chief Accounting Officer   •       –      –    2023-03-01 4 S $45.65 $4,565 D/D (100) 23,048 4%     
   Huizenga Theodore Alan SVP, Chief Accounting Officer   •       –      –    2023-03-01 4 A $0.00 $0 D/D 7,590 23,148     -
   Pinion John Richard See Remarks   •       –      –    2023-03-01 4 D $45.65 $183,239 D/D (4,014) 76,160     -
   Pinion John Richard See Remarks   •       –      –    2023-03-01 4 S $45.26 $169,951 D/D (3,755) 80,174 4%     
   Pinion John Richard See Remarks   •       –      –    2023-03-01 4 A $0.00 $0 D/D 24,663 83,929     -
   Parschauer Karah Herdman EVP and Chief Legal Officer   •       –      –    2023-03-01 4 S $45.25 $143,035 D/D (3,161) 56,139 4%     
   Parschauer Karah Herdman EVP and Chief Legal Officer   •       –      –    2023-03-01 4 A $0.00 $0 D/D 24,663 59,101     -
   Kassberg Thomas Richard CBO & EVP   •       –      –    2023-03-01 4 D $45.65 $154,936 D/D (3,394) 246,860     -
   Kassberg Thomas Richard CBO & EVP   •       –      –    2023-03-01 4 S $45.27 $89,091 D/D (1,968) 250,254 4%     
   Kassberg Thomas Richard CBO & EVP   •       –      –    2023-03-01 4 A $0.00 $0 D/D 24,663 252,222     -
   Bedrosian Camille L EVP and Chief Medical Officer   •       –      –    2023-03-01 4 S $45.25 $175,615 D/D (3,881) 46,720 4%     
   Bedrosian Camille L EVP and Chief Medical Officer   •       –      –    2023-03-01 4 A $0.00 $0 D/D 2,663 50,601     -
   Huang Dennis Karl See Remarks   •       –      –    2023-03-01 4 D $45.65 $483,844 D/D (10,599) 64,715     -
   Huang Dennis Karl See Remarks   •       –      –    2023-03-01 4 S $45.65 $17,758 D/D (389) 75,314 4%     
  628 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 3 of 26
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us